Here’s some of the latest financings we haven’t mentioned…

• Calistoga Pharmaceuticals will live to see another year. The developer of PI3K delta isoform inhibitors, which might be more specific for liquid tumors than its non-selective counterparts, has received $30M in financing from its VC parents to keep it going. VC backers include Frazier Healthcare Ventures, Alta Partners, Three Arch Partners, and Amgen Ventures. [Xconomy]

• NABsys Inc. has closed a $4M equity round that will be used to advance the company’s solid-state DNA sequencing platform. NABsys combines physics, biology and computer science to create an electronic, solid-state DNA sequencing platform. The platform eliminates dependency on a polymerase enzyme (eg PCR) and uses electronic detection of DNA and algorithms for DNA rebuilding. The financing came from Point Judith Capital, Slater Technology Fund and other undisclosed investors. [Mass High Tech]

• Kamada announced yesterday that, pursuant to an agreement dated February 23, 2009, it completed a private allocation of 2,621,723 shares of its common stock to a select group of investors, including Ralf Hahn, Chairman of the Board and one of the controlling shareholders, and UDT Med Holdings LLC, New York. Kamada will pocket $7M to advance its biotherapeutic pipeline. [Genetic Engineering & Biotechnology News]

• Synageva BioPharma said it has brought in an additional $3M from two new investors, Yasuda Enterprise Development Co. and Hunt BioVentures, bringing its total Series A to $33M. Synageva previously announced a $30M commitment in April to fund its pipeline of novel proteins, antibodies and follow-on biologics. [BusinessWire]

• Finally, Sanovia Corp. has raised $8M in a Series C round led by Chrysalis Ventures, HLM Venture Partners and Claritas Capital. The funding brings Sanovia’s total financing history to $16M. Sanovia provides pharmaceutical management products and services to health plans, such as automated prior authorization management, fraud and abuse detection and medication management solutions. [peHUB]

And we’re done…

Image from nwinnovation

Related Posts